Found: 29
Select item for more details and to access through your institution.
The PREgnancy and FERtility (PREFER) Study Investigating the Need for Ovarian Function and/or Fertility Preservation Strategies in Premenopausal Women With Early Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.690320
- By:
- Publication type:
- Article
VISTA: A Promising Target for Cancer Immunotherapy?
- Published in:
- ImmunoTargets & Therapy, 2021, v. 10, p. 185, doi. 10.2147/ITT.S260429
- By:
- Publication type:
- Article
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy: Case Report.
- Published in:
- Current Oncology, 2024, v. 31, n. 5, p. 2856, doi. 10.3390/curroncol31050217
- By:
- Publication type:
- Article
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patterns of care at the end of life: a retrospective study of Italian patients with advanced breast cancer.
- Published in:
- BMC Palliative Care, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12904-024-01460-0
- By:
- Publication type:
- Article
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 351, doi. 10.1007/s10549-023-07116-6
- By:
- Publication type:
- Article
Comment on "Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta‑analysis".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 191, n. 2, p. 269, doi. 10.1007/s10549-021-06436-9
- By:
- Publication type:
- Article
Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 1, p. 27, doi. 10.1007/s10549-018-5055-9
- By:
- Publication type:
- Article
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 245, doi. 10.1007/s10549-018-4806-y
- By:
- Publication type:
- Article
Treatment with aromatase inhibitors and markers of cardiovascular disease.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 160, n. 2, p. 261, doi. 10.1007/s10549-016-3985-7
- By:
- Publication type:
- Article
Impact of Age on Clinical Outcomes and Efficacy of Adjuvant Dual Anti-HER2 Targeted Therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak.
- Published in:
- European Journal of Clinical Investigation, 2020, v. 50, n. 9, p. 1, doi. 10.1111/eci.13315
- By:
- Publication type:
- Article
Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Italian Multicenter Retrospective Cohort Study.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 880, doi. 10.1634/theoncologist.2015-0020
- By:
- Publication type:
- Article
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.
- Published in:
- Clinical Medicine Insights: Reproductive Health, 2019, v. 13, p. 1, doi. 10.1177/1179558119864584
- By:
- Publication type:
- Article
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review.
- Published in:
- Clinical Medicine Insights: Reproductive Health, 2019, v. 13, n. 2, p. N.PAG, doi. 10.1177/1179558119864584
- By:
- Publication type:
- Article
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920931816
- By:
- Publication type:
- Article
Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer.
- Published in:
- Clinical Medicine Insights: Oncology, 2020, v. 14, p. 1, doi. 10.1177/1179554920931816
- By:
- Publication type:
- Article
Update on the Management of Breast Cancer during Pregnancy.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3616, doi. 10.3390/cancers12123616
- By:
- Publication type:
- Article
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 1, p. 160, doi. 10.1002/ijc.32789
- By:
- Publication type:
- Article
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article